Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-05-28

Chi-square Test

Categorical-data hypothesis testing in pharmacology research

Past RGUHS + DNB + MPMSU + MUHS · 11 RGUHSJun '24 DNBMay '24 RGUHSMay '22 RGUHSNov '21 MUHSSummer '19 MPMSUMay '18 RGUHSNov '17 MPMSU2010 RGUHSOct '08 RGUHSSep '07 MPMSU2002

Introduction

  • Definition — Chi-square (χ2) is a family of non-parametric inferential tests comparing observed (O) and expected (E) frequencies in categorical data against the χ2 sampling distribution.
  • Test family — Four named variants — Pearson goodness-of-fit, Pearson independence, χ2 of homogeneity, and McNemar (paired) — plus Mantel–Haenszel (stratified), Cochran–Armitage (trend), and the likelihood-ratio G2 statistic.
  • Historical anchor — Pearson 1900 introduced χ2 as the first general goodness-of-fit test; Yates 1934 added the continuity correction; Fisher 1934 defined the exact alternative; McNemar 1947 adapted it for paired binary data.
  • MD pharmacology relevance — First-line test for categorical outcomes in pharmacology — drug-vs-placebo response rates, ADR incidence, genotype frequencies, and ordered-category survey responses.
  • RGUHS / NMC — Recurring 10-mark RGUHS LAQ (6 verbatim recurrences in the past-question corpus + 3 MPMSU); NMC PG competency PG2.5 — apply appropriate biostatistical tests.
Continue reading

Chi Square Test

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.